Indian Journal of Clinical and Experimental Ophthalmology

Print ISSN: 2395-1443

Online ISSN: 2395-1451

CODEN : IJCEKF

Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 389

PDF Downloaded: 275


Get Permission Morskole, Som, Dubey, Kumar, Bamhane, and Tekam: A study of ocular manifestations in HIV positive patients


Introduction

Human Immunodeficiency Virus (HIV) was discovered in 1983 by Barre- Sinoussi Et Al.1 According to the global statistics of 2020, released in June 2020, 38 million people are found to be HIV positive. In 2019 around 6.9 lakhs people have died from HIV related illness.2 HIV prevalence in India in 2019 was estimated to be around 0.22% (23.49 lakhs). Mizoram has the highest prevalence with 2.32% and Tamil Nadu being 0.23%. In 2019 in estimated annual new HIV infections ranging between 2,000 to 3,000 in Madhya Pradesh.

This infection gradually depletes CD4 lymphocytes, resulting in decreased blood levels of this crucial subset of “helper” T cells.3 Blindness due to HIV-related complications is a concern that endangering the life of people living with HIV. Its prevalence ranges from 6.9%-23%.4 The prevalence of HIV-related ocular manifestations are inversely proportional to CD4+ T cell count.5 By the introduction of highly active anti-retroviral therapy (HAART) it has changed both the prevalence and pattern of HIV- related ocular manifestation.6 Before HAART, CMV retinitis was the commonest ocular manifestation.7 In the HAART era, incidence of CMV retinitis, Kaposi‟s sarcoma, retinal microvasculopathy and opportunistic retinal infections were also found tobe lower.7, 8 Ocular lesions usually occur in the late phase of the disease but can also occur in the early stages.9 These manifestations may be the initial presentation of a systemic infection in an asymptomatic positive patient.10 Early diagnosis and appropriate treatment can help in prevention of these sight threatening complications and thus decreasing the prevalence of blindness in these cases.

Objectives

  1. To determine the prevalence of ocular manifestation in HIV positive patients attending ART center in Gandhi Medical College, Bhopal.

  2. To evaluate the ocular manifestations of HIV positive patients.

  3. Correlation of ocular lesions with CD4 counts in HIV positive patients.

Materials and Methods

The study was conducted as a hospital based Prospective Observational study at ART center in association with Department of Medicine and Department of Ophthalmology, Gandhi Medical College, Bhopal, Madhya Pradesh during the study period of 2 years i.e. from 1st November 2018 to 30th September 2020.

Seropositive HIV patients attending ART center; referred to department of ophthalmology for ocular complaints or attending ophthalmic OPD of Gandhi Medical College and willing to participate in the study were included whereas HIV patients with other congenital or pre-existing ocular diseases unrelated to HIV or history of trauma and not willing to participate in the study were excluded.

Before commencing the study, Ethics committee approval was obtained from the Ethics committee of Gandhi medical college, Bhopal. Informed and written consent was taken from all the patients. Socio-demographic data such as age, gender, socioeconomic status, occupation, marital status and place of residence was obtained from all the study participants and entered in questionnaire. For maintaining the confidentiality of the patient, UID number was allotted. Name of the patients were neither disclosed to any other person nor published in any written form. Even the registration number in the ART clinic which is unique to each patient was neither disclosed nor published. Instead the OPD number was used as the reference number. History of co-morbidities, mode of infection, duration of HIV infection, treatment history was obtained an entered in questionnaire. Patients were asked about the presence or absence of ocular symptoms.

The patient were subjected to thorough ophthalmologic evaluation which includes best corrected visual acuity determined using Snellen’s chart; IOP determined using Schiotz /applanation tonometer. A simple torch light examination performed to look at the lids and adnexa. Anterior segment examination was done on slit lamp which includes examination of Lid, Conjunctiva, Cornea, Anterior chamber, Iris, Pupil and Lens Anterior and Posterior segment examination was done on indirect ophthalmoscopy which includes examination of Vitreous, Choroid, Retina, Optic nerve. For dilatation one drop of phenylephrine and tropicamide was instilled at an interval of 10-15 minutes. After dilatation Fundus examination was performed with an indirect ophthalmoscope and 20 D or 28D lens.

Special investigations were done in certain cases such as Gonioscopy, Fluorescein Stain, Corneal Sensation and Schirmers Test, required for evaluation of anterior segment. Fundus photography, Fundus Fluorescein Angiography and Optical Coherence Tomography was done for evaluation of posterior segment.

The findings of investigations done in ART center were noted (CBC, ESR, CD4 COUNTS, LFT, RFT, USG ABDOMEN etc.). Additional investigation such as CMV serology and Histopathology of mass lesions were done in co-ordination with ART center whenever required.

All ocular findings were noted and the final ophthalmic status of patient were noted. In case of getting abnormal ophthalmic findings, it was examined and confirmed by senior ophthalmologist.   Positive findings were treated according to standard management protocol.

Counselling was done regarding the ocular manifestations which may occur during the course of the disease and need for ophthalmic screening. The ophthalmic status was revealed to the patient after necessary counselling and need for periodic review was suggested.

Statistical analysis

Data was compiled using MS excel and analysed using IBM SPSS software version 20. Data was grouped and expressed as proportions. Chi square test was used to assess the association between proportions. P value <0.05 was considered statistically significant.

Results

In present study enrolled total of 69 patients of HIV fulfilling the inclusion criteria during the study periods.

Table 1

Distribution of patients and ocular manifestation according to demographic profile

Demographic Characteristics

Frequency (n=69)

Percentage

No of patients with ocular manifestations

Proportion

Age group (in years)

≤20

4

5.8

2

50

21-40

43

63.7

17

39.53

41-60

20

27.5

15

75

>60

2

2.9

2

100

Gender

Male

46

66.7

28

60.8

Female

23

33.3

8

34.78

Marital status

Married

57

82.6

28

48.28

Unmarried

10

14.5

6

60

Widowed

2

2.9

2

100

Socioeconomic status

Lower

26

37.6

18

66.6

Lower middle

17

24.6

8

47.05

Upper lower

7

10.14

3

42.8

Upper middle

16

23.18

6

37.5

Upper

3

4.3

1

33.33

The mean age of the study group was 36.8±12.05 years (Range-9 to 72 years). The proportion of Ocular manifestations were maximum in males (60.8%). Though, majority of patients with HIV were married (82.6%), proportion of ocular manifestations were maximum in widowed followed by unmarried patients. Majority of the patients with HIV belonged to lower socio-economic status (37.6%) and proportion of ocular manifestations were also higher in this socioeconomic group (66.6%).

Table 2

Distribution of according clinical history

Variables

Frequency (n=69)

Percentage

No of patients with ocular manifestations

Proportion

Presentation

Symptomatic

33

47.8

27

81.8

Asymptomatic

36

52.17

9

25

Mode of infection

Heterosexual

19

27.5

4

21.05

Needle injury

6

8.9

4

66.6

Blood transfusion

3

4.3

1

33.3

Intravenous drug use

5

7.2

3

60

Perinatal

2

2.8

1

50

Unknown

35

50.7

25

71.42

Comorbidities

Tuberculosis

12

17.4

8

66.6

Tubercular meningitis

3

4.3

3

100

Herpes Zoster

2

2.9

2

100

Syphilis

1

1.4

1

100

RA and TB

1

1.4

1

100

Others

6

8.6

4

66.6

No comorbidities

44

63.7

17

38.63

The proportion of ocular manifestations in asymptomatic patients is around 25%. However the proportion of ocular manifestation were more with symptomatic patients (81.8%). Higher proportion of ocular manifestations were noted in patients with unknown mode of transmission (71.42%). The proportion of ocular manifestations were more in patients who had associated tubercular meningitis, herpes zoster infection, syphilis and rheumatoid arthritis with tuberculosis (100%).

Table 3

Distribution according to HIV characteristics

Variables

Frequency (n=69)

Percentage

No of patients with Ocular manifestations

Proportion

Duration since diagnosis of HIV and initiation of HAART

<1 year

7

10.1

6

85.7

1-5 year

40

58.0

20

50

>5 year

22

31.9

10

45.45

Compliance on HAART

Compliance

63

91.3

32

50.79

Noncompliance

6

8.7

4

66.66

CD4 count

100-150

14

20.28

11

78.5

150-250

39

56.5

19

48.7

250-500

14

20.28

5

35.7

>500

2

2.8

1

50

The proportion of ocular manifestations were more in those who had HIV infection with duration <1 year, non-compliant to HAART and with low CD4 counts.

Figure 1

Prevalence of ocular manifestations in HIV patients

https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/6f348746-3766-465f-86b9-be5fd938b4bd/image/7a2a2924-ba20-4a25-bf91-c1ec059209b2-uimage.png

Ocular manifestations were observed in total 36 (52.17%) patients. Among them, unilateral ocular manifestations were observed in 11 (15.9%) cases and bilateral involvement in 25 (36.2%) out of 69 patients. However 33(47.82%) patients had no ocular manifestations out of total.

Table 4

Distribution according to ocular manifestations

Ocular manifestations

Frequency (n=69)

Percentage

Ocular Adnexal manifestations

Herpes Zoster ophthalmicus

2

2.8

Blepharitis

1

1.4

Scleritis

1

1.4

Conjunctivitis

2

2.8

Conjunctival squamous cell carcinoma

1

1.4

Total

7

10.14

Anterior segment

Dry eye

2

2.8

Cataract

4

5.7

Keratitis

4

5.7

Anterior uveitis

1

1.4

Glaucoma suspect

1

1.4

Total

12

17.39

Posterior segment

Retinal microvasculopathy

11

15.9

Posterior uveitis

2

5.7

Age related macular degeneration

1

2.8

Cytomegalovirus retinitis

2

5.7

Retinal Detachment

2

2.8

Vasculitis

1

1.4

Vitritis

1

1.4

Endogenous Endophthalmitis

1

1.4

Total

21

30.43

Neuro-opthalmic

Lateral Rectus paresis

1

2.8

Papilledema

2

5.7

Total

3

4.34

Table 4 reveal ocular manifestations among patients with HIV. Ocular adnexal involvement was noted in 7(10.14%) patients whereas anterior segment and posterior segment manifestations were noted in 12(17.39%) and 21(30.43%) patients respectively. Neuro-ophthalmic manifestations was noted in 3(4.34%) patients.

Table 5

Association of CD4 count with ocular manifestation in HIV patients

Ocular manifestations

CD4 count

χ2

P value

100-150

150-250

250-500

>500

Herpes Zoster ophthalmicus

1(7.1)

1(2.6)

0(0)

0 (0)

1.389

0.708

Blepharitis

0(0)

1(2.6)

0(0)

0 (0)

0.781

0.854

Scleritis

1(7.1)

0(0)

0(0)

0 (0)

3.986

0.263

Conjunctivitis

0(0)

1(2.6)

1(7.1)

0 (0)

1.389

0.708

Conjunctival squamous cell carcinoma

1(7.1)

0(0)

0(0)

0 (0)

3.986

0.263

Dry eye

0 (0)

2 (5.1)

0(0)

0 (0)

1.584

0.663

Cataract

1 (7.1)

3 (7.7)

0 (0)

0 (0)

1.288

0.732

Anterior uveitis

1(7.1)

0

0 (0)

0 (0)

3.986

0.263

Keratitis

2 (14.3)

2(5.1)

0

0 (0)

2.864

0.413

Glaucoma suspect

0 (0)

0 (0)

1(7.1)

0

3.986

0.263

Retinal microvasculopathy

2 (14.3)

8(20.5)

1 (7.1)

0 (0)

1.825

0.610

Posterior uveitis

0 (0)

1(2.6)

1 (7.1)

0 (0)

1.389

0.708

ARMD

0 (0)

1(2.6)

0 (0)

0 (0)

0.781

0.854

CMV retinitis

2 (14.3)

0

0 (0)

0 (0)

8.092

0.044

Retinal Detachment

0 (0)

2 (5.1)

0 (0)

0 (0)

1.584

0.663

Vasculitis

1 (7.1)

0 (0)

0 (0)

0 (0)

3.986

0.263

Vitritis

0 (0)

1 (2.6)

0 (0)

0 (0)

0.781

0.854

Endogenous Endophthalmitis

1 (7.1)

0 (0)

0 (0)

0 (0)

3.986

0.263

Lateral rectus paresis

0 (0)

1 (2.6)

0 (0)

0 (0)

0.781

0.854

Papilloedema

0 (0)

0 (0)

1 (7.1)

1 (50)

18.14

0.001

Ocular manifestations were not significantly associated with CD4 count (p>0.05) except CMV retinitis which was significantly associated with lower CD4 count (<150 in 14.3%cases). Papilledema was significantly associated with higher CD4 count (p<0.05).

Discussion

Ocular manifestations in these patients were first documented by Maclean more than 20 years ago.11 The ocular manifestations may results in opportunistic infections, vascular abnormalities, neoplasms, neuro-ophthalmic conditions, and adverse effects of medications.11

Our study observed prevalence of ocular manifestation in 52.2%, of them, bilateral involvement was noted in 36.2% cases. In study by Hothi et al12 ocular symptoms were observed among 39% cases. In study by Ganekal et al13 46% patients had ocular manifestations. Labh et al13 documented ocular manifestation in 40% patients.

Among adnexal manifestation, present study found Herpes zoster ophthalmicus, and conjunctivitis in 2.8% of the patients, whereas blepharitis, scleritis and conjunctival squamous cell carcinoma was noted in 1.4% patients. Rare case of scleritis in patients with HIV may be due to rheumatoid arthritis. In study by Sharma et al14 lid and adnexal manifestations were seen in 8% patients, 3.3% patients had style and 1.3% of patients had molluscum contagiosum and HZO were seen in 1.3% in each. Blepharitis, Meibomitis, and entropion were seen in one patient each.

In study by Amsalu et al15 conjunctival squamous cell growth was seen in 3.8% of patients and blepharitis in 5% of patients. Thus it can be fairly said that Adnexal involvement is common in patients with HIV, most common form being lid involvement.

In the present study, anterior segment manifestations were noted in 17.39% patients, of them, Cataract was the most common (5.7%), keratitis and dry eye were noted in 2.8% cases each. of patients. Jabs et al16 also observed cataract as the leading cause of blindness in HAART era as incidence of Retinal detachment decreases due to HAART. Acharya et al17 documented lid infections as most common anterior segment manifestation followed by corneal opacity, Herpes zoster ophthalmicus, and Healed anterior uveitis.

The present study found Retinal microvasculopathy to be the most common posterior segment manifestation noted in 15.9% of patients whereas posterior uveitis and CMV retinitis was the next common ocular manifestation involving posterior segment observed in 5.7% of patients each followed by retinal detachment in 2.8% patients. The finding of present study were supported by findings of Pathai et al18 in which CMV retinitis was most common posterior segment manifestation in HIV patients which was significantly associated with low CD4 count. Similarly Acharya et al17 found HIV microangiopathy, followed by CMV retinitis as the most common manifestations in patients with HIV. Posterior segment involvement comes with angiopathies which is hardly reversed. As seen further, the involvement increases with loss of CD4 count, so measures need to be taken to maintain CD4 count so as to delay the posterior segment involvement and other complications.

Optic neuropathies in HIV patients may be due to inflammation, compression, infiltration, infection or vaso-occlusion lesions. Intracranial manifestations associated with HIV like Cryptococcal meningitis and intracerebral toxoplasma cysts, can affect the eyes, and leads to nerve palsies. Neuro ophthalmic complications in HIV positive patient have also been reported in the absence of associated opportunistic infections.19 The present study found Neuro -ophthalmic manifestations in 3 (4.34%) patients. Acharya et al17 found hyperemic disc, pupillary abnormalities and papilledema as the common neuro ophthalmic manifestations in HIV patients.

Overall ocular manifestations were not significantly associated with CD4 count (p>0.05) except CMV retinitis which was significantly associated with lower CD4 count (<150 in 14.3% cases). Acharya et al17 concluded risk of Retinal microangiopathy, Conjunctival microvasculopathy, Keratoconjuctivitis sicca, VZV retinitis, CMV retinitis with progressive loss of CD4 count <100 cells/microlitre.

Singalavanija et al20 found anterior segment involvement like dry eye, anterior and posterior blepharitis was higher in those with CD4 count 200- 500cells. CMV retinitis is manifested when the CD4 counts gets lower, between CD4 counts 200-500 cells mild ocular manifestations are seen as evidenced by above studies.

Conclusion

Ocular manifestations in HIV positive patients has a wide range of presentation and outcome from asymptomatic patients to permanent blindness. Blindness which can be prevented in a significant number of patients if properly managed and screened early. The posterior segment manifestations were found to be more prevalent. Every HIV patient must be educated about their ocular condition and should be advised to undergo regular ophthalmic examinations. Health care professionals also should be educated and trained in every aspect so as to pick up early cases of ophthalmic manifestations of HIV and should have coordination with ART center for easy assessment, detection and treating of vision-threatening ocular lesions at the earliest possible.

Strength of Study

  1. As a result of screening, ocular manifestations were diagnosed at early stage and appropriate timely treatment was given which delay or reverse the ocularmorbidity.

  2. Helpful in better understanding of presentation and clinical finding of ocular manifestations in HIV positivepatients.

Weakness of Study

  1. Late presentation of patients at the studyarea

  2. Maximum patients reported only when they have ocularmanifestations

  3. Limited study period

  4. Smaller samplesize

  5. Covid-19 Pandemic affects the sample size taken for the study

Opportunities of Study

  1. Repeated screening may lead to increase in awareness regarding ocular involvement in HIV patients

Source of Funding

None.

Conflict of Interest

The authors declare that there is no conflict of interest.

References

1 

F Barré-Sinoussi JC Chermann F Rey MT Nugeyre S Chamaret J Gruest Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)Science1983220459986871

2 

Global HIV and AIDS statistics UNAIDS 2020http://www.unaids.org/en/resources/fact-sheet

3 

AS Fauci G Pantaleo S Stanley D Weissman Immunopathogenic mechanisms of HIV infectionAnn Intern Med1996124765463

4 

SU Shah S P Kerkar AR Pazare Evaluation of ocular manifestation and blindness in HIV/AIDS patients on HAART in tertiary care hospital in western IndiaBr J Ophthalmol20099318890

5 

BJ Turner FM Hecht RB Ismail CD4+ T-lymphocyte measure in the treatment of individuals infected with human immunodeficiency virus type 1: a review for clinical practitionersArch Intern Med199415414156173

6 

K Kartik J Biswas N Kumarasamy Impact of highly active antiretroviral therapy on ophthalmic manifastations in human immunodeficiency virus/acquired immune deficiency syndromeIndia J Ophthalmolo20085653913

7 

ET Cunningham TP Margolis Ocular manifestation of HIV infection: current conceptsN Engl J Med1998339423644

8 

DE Goldberg LM Smithen A Angelilli WR Freeman HIV-associated retinopathy in the HAART eraRetina200525563349

9 

S Sudharshan J Biswas Introduction and immunopathogenesis of acquired immune deficiency syndromeIndian J Ophthalmol200856535762

10 

S Jalali U Rao V Lakshmi Acute retinal necrosis syndrome in a HIV positive case: The first case reported from IndiaIndian J Ophthalmol1996442957

11 

KB Feroze J Wang Ocular manifestations of HIV. [Internet] StatPearls Publishing2019

12 

HS Hothi NR Gohil NV Parekh SS Patel A prevalence study of ocular manifestations in HIV positive patients on highly active anti-retroviral therapyBiomed Res Clin Prac2019414

13 

S Ganekal V Jhanji S Dorairaj A Nagarajappa Evaluation of ocular manifestations and blindness in HIV/AIDS patients in a tertiary care hospital in South IndiaOcul Immunol Inflamm201220533641

14 

M Sharma A Chauhan G Sharma V Chauhan Ocular manifestations in patients attending antiretroviral therapy centre at a tertiary care hospital in Himachal Pradesh, IndiaIndian J Med Res20181475496500

15 

A Amsalu K Desta D Delelegne D Delelegne Ocular manifestation and their associated factors among HIV/AIDS patients receiving highly active antiretroviral therapy in Southern EthiopiaInt J Ophthalmol201710577681

16 

DA Jabs Ocular manifestations of HIV infectionTrans Am Ophthalmol Soc19959362383

17 

PK Acharya KC Venugopal DP Karimsab S Balasubramanya Ocular Manifestations in Patients with HIV Infection/AIDS who were Referred from the ART CentreJ Clin Diagn Res2012610175660

18 

S Pathai A Deshpande C Gilbert SD Lawn Prevalence of HIV-associated ophthalmic disease among patients enrolling for antiretroviral treatment in India: a cross-sectional studyBMC Infect Dis20099158

19 

FR Bahls SM Sumi Cryptococcal meningitis and cerebral toxoplasmosis in a patient with acquired immune deficiency syndromeJ Neurol Neurosurg Psychiatry198649332830

20 

T Singalavanija S Ausayakhun C Tangmonkongvoragul Anterior segment and external ocular disorders associated with HIV infectionsin the era of HAART in Chiang Mai University Hospital, a prospective descriptive cross sectional studyPLoS One2018132e0193161



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Original Article


Article page

72-78


Authors Details

Sheetal Morskole*, Vivek Som, Aditi Dubey, Kavita Kumar, Preeti Bamhane, Dev Kumar Tekam


Article History

Received : 24-09-2021

Accepted : 12-10-2021


Article Metrics


View Article As

 


Downlaod Files